![](https://bsmedia.business-standard.com/_media/bs/img/article/2024-08/30/thumb/fitandfill/400X400/1725038648-2508.jpg)
Teva faces fine for disparaging rival multiple sclerosis medicine: Report
Teva, the world's largest generic drugmaker, will be hit with an EU antitrust fine in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone, people with direct knowledge of the matter said on Tuesday. …